Gerresheimer AG, DE000A0LD6E6

Gerresheimer AG, DE000A0LD6E6

07.09.2022 - 08:03:43

Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry

or www.stevanatogroup.com

Contact Press Gerresheimer AG

Ueli Utzinger Group Senior Director Marketing & Communication T +49 211 6181-250ueli.utzinger@gerresheimer.com

Contact Investor Relations Gerresheimer AG Carolin Nadilo Corporate Senior Director Investor Relations T +49 211 6181-220carolin.nadilo@gerresheimer.com

?

Media contact Stevanato Group

Cassie GonzalezstevanatoUS@teamlewis.com

?

Investor Relations Stevanato Group

Lisa Mileslisa.miles@stevanatogroup.com

About Gerresheimer

Gerresheimer is the global partner for pharmaceutics, biotech, healthcare, and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging solutions and drug delivery systems. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 11,000 employees and generated annual revenues in 2021 of around EUR 1.5b. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.

For more information: www.gerresheimer.com

?

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life science industries. The Group offers an integrated and comprehensive portfolio of products, processes and services that address customers' needs across the entire drug lifecycle at every stage of development, clinical and commercial. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are essential to its ability to offer value-added solutions to customers.

For more information: www.stevanatogroup.com

?

07.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Gerresheimer AG Klaus-Bungert-Str. 4 40468 D?sseldorf

Germany Phone: +49-(0)211/61 81-314 Fax: +49-(0)211/61 81-121 E-mail: carolin.nadilo@gerresheimer.com Internet: http://www.gerresheimer.com ISIN: DE000A0LD6E6 WKN: A0LD6E Indices: MDAX (Aktie) Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1436851 ? End of News DGAP News Service

1436851??07.09.2022?CET/CEST

@ dgap.de